drugset
drugset / Trial / NCT02614352

Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male Subjects

NCT02614352 ↗

Phase 1 Unknown 60 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd
RandomizedCrossoverOpen-label

Summary

Primary object : Evaluate pharmacokinetic property AG1502 and Candesartan 32mg and Atorvastatin 40mg in healthy male subjects.

Timeline

Start
—
Primary completion
2016-02
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AG1502 Unknown — —
Subject Atorvastatin Small molecule 40 mg —
Subject Candesartan Unknown 32 mg —

Indications

No indication recorded.